REGULATORY-ADAPTIVE STATUS IN COMPARISON OF BISOPROLOL AND SOTALOL EFFICACY IN VENTRICULAR RHYTHM DISORDERS
https://doi.org/10.15829/1560-4071-2018-1-51-56
Abstract
Aim. To compare the efficacy of combinational therapy with added bisoprolol or sotalol, in patients with ventricular rhythm disorders (VRD) via the assessment of regulatory-adaptive status (RAS).
Material and methods. Sixty VRD patients with II-III Bigger type or I-IV Lown, and with essential systemic hypertension II-III stages and/or coronary heart disease, were randomized to two groups. Group 1 received bisoprolol 6,4±1,8 mg daily, group 2 — sotalol 166,7±49,4 mg daily. As combinational therapy, all patients were taking lisinopril (12,5±4,1 mg daily and 14,0±4,6 mg daily, respectively). At baseline and in 6 months of combinational therapy, the following measures were done: quantitative assessment of RAS (by the test with cardiorespiratory synchronism), echocardiography, threadmill-test, 6-minute walking test, Holter blood pressure and electrocardiography monitoring, life quality assessment.
Results. Sotalol less prominently decreases RAS than bisoprolol. Both equally improved structural and functional condition of the heart, increased exercise tolerance, showed comparable hypotensive and antiarrhythmic effects. Sotalol, comparing to bisoprolol, improved life quality more significantly.
Conclusion. In VRD patients with essential systemic hypertension and/or coronary heart diease, combinational therapy with sotalol, comparing to bisoprolol, might be more preferrable due to less negative influence on RAS.About the Authors
V. G. Tregubov
Kubansky State Medical University of the Ministry of Health
Tregubov Vitaliy Germanovich
Krasnodar
I. Z. Shubitidze
Kubansky State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Shubitidze Iosif Zurabovich
Krasnodar
S. G. Kanorskii
Kubansky State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Kanorskii Sergey Grigorevich
Krasnodar
V. M. Pokrovsky
Kubansky State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Pokrovsky Vladimir Mikhailovich
Krasnodar
References
1. Cantillon DJ. Evaluation and management of premature ventricular complexes. Cleve Clin J Med 2013; 80 (6): 377-87.
2. Treshkur TV, Tulintseva TE, Parmon EV, et al. Conservative treatment of non-ischemic ventricular arrhythmias: experience and prospects. Kardiologiia i serdechno-sosudistaia khirurgiia 2013; 6 (5): 58-66. (In Russ.) Трешкур Т. В.,Тулинцева Т.Э., Пармон Е. В. и др. Консервативная терапия неишемических желудочковых аритмий: опыт и перспектива. Кардиология и сердечно-сосудистая хирургия 2013; 6 (5): 58-66.
3. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36 (41): 2793-867.
4. Tarasov AV. Security issues in antiarrhythmic therapy. Consilium Medicum 2014; 16 (10): 44-9. (In Russ.) Тарасов А. В. Вопросы безопасности антиаритмической терапии. Consilium Medicum 2014; 16 (10): 44-9.
5. Prystowsky EN, Padanilam BJ, Joshi S, et al. Ventricular arrhythmias in the absence of structural heart disease. J Am Coll Cardiol 2012: 59 (20): 1733-44.
6. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33 (14): 1787-847.
7. Pokrovskii VM, Polischuk LV. Cardiorespiratory synchronism in estimation of regulatory and adaptive organism status. Journal of Integrative Neuroscience 2016; 15 (1): 19-35.
8. Pokrovskii VM. Cardio-respiratory synchronism in assessment of regulatory-adaptive capabilities of an organism. Krasnodar: Kuban-Kniga 2010; 244 р. (In Russ.) Покровский В. М. Сердечно-дыхательный синхронизм в оценке регуляторноадаптивных возможностей организма. Краснодар: Кубань-Книга 2010; 244 с.
9. Makukhin VV, Pokrovskii VM, Tregubov VG. Parameters of echocardiography and the regulatory-adaptive status of patients with premature ventricular beats of the different causes. Kubanskii nauchnyi meditsinskii vestnik 2010; 6: 84-7. (In Russ.) Макухин В. В., Покровский В. М., Трегубов В. Г. и др. Показатели эхокардиографии и состояние регуляторно-адаптивного статуса у пациентов с желудочковой экстрасистолией различного происхождения. Кубанский научный медицинский вестник 2010; 6: 84-7.
10. Pokrovskii VM, Ponomarev VV, Artyushkov VV, et al. System for determining cardiorespiratory synchronism in human. 2009; Russia, patent 86860. (In Russ.) Покровский В. М., Пономарев В. В., Артюшков В. В. и др. Система для определения сердечно-дыхательного синхронизма у человека. Россия. 2009. Патент № 86860.
11. Prokofiev AB. Antiarrhythmic drugs influence on the quality of life of patients with heart rhythm disorders. Lekarstvennye preparaty i racionalnaia farmakoterapiia 2013; 1: 39-44. (In Russ.) Прокофьев А. Б. Влияние антиаритмических лекарственных препаратов на качество жизни больных с нарушениями сердечного ритма. Лекарственные препараты и рациональная фармакотерапия 2013; 1: 39-44.
12. Kanorskii SG, Tregubov VG, Pokrovskiy VM. Advantages of quinapril therapy in patients with arterial hypertension and functional class I-II chronic heart failure with preserved left ventricular ejection fraction. Kardiologiia 2012; 52 (4): 31-8. (In Russ.) Канорский С. Г., Трегубов В. Г., Покровский В. М. Преимущества терапии квинаприлом у пациентов с артериальной гипертензией и хронической сердечной недостаточностью I-II функционального класса и сохраненной фракцией выброса левого желудочка. Кардиология 2012; 52 (4): 31-8.
13. Tregubov VG, Pokrovskiy VM, Kanorskii SG. Quantitative evaluation of regulatory adaptive status in determining the severity of chronic heart failure. Clinical Medicine 2012; 8: 32-5. (In Russ.) Трегубов В. Г., Покровский В. М., Канорский С. Г. Количественная оценка регуляторно-адаптивного статуса в определении тяжести хронической сердечной недостаточности. Клиническая медицина 2012; 8: 32-5.
14. Minuskina LO. Bisoprolol: opportunities in the treatment of hypertension. Kardiologiia 2012; 52 (6): 80-5. (In Russ.) Минушкина Л. О. Бисопролол: возможности в лечении артериальной гипертонии. Кардиология 2012; 52 (6): 80-5.
15. Sulimov VA, Napalkov DA. Role of sotalol in the treatment of heart rhythm disturbances: modern approaches. Pharmateca 2009; 6: 16-21. (In Russ.) Сулимов В. А., Напалков Д. А. Роль соталола в лечении нарушений сердечного ритма: современные подходы. Фарматека 2009; 6: 16-21.
Review
For citations:
Tregubov V.G., Shubitidze I.Z., Kanorskii S.G., Pokrovsky V.M. REGULATORY-ADAPTIVE STATUS IN COMPARISON OF BISOPROLOL AND SOTALOL EFFICACY IN VENTRICULAR RHYTHM DISORDERS. Russian Journal of Cardiology. 2018;(1):51-56. (In Russ.) https://doi.org/10.15829/1560-4071-2018-1-51-56
Views:
890
Email this article 